Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Mar. 24 announced the initiation of a pivotal global Phase 2 trial of AP26113 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated with crizotinib. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares after opening at $8.04 moved to $8.20 on last trade day and at the end of the day closed at $7.98. Company price to sales ratio in past twelve months was calculated as 32.50 and price to cash ratio as 6.25. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a positive weekly performance of 1.79%.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) yesterday declared positive top-line information from its randomized, twofold unseeing, controlled Phase 2 trial of IMO-8400 in 32 patients with moderate-to-serious plaque psoriasis. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) shares advanced 17.78% in last trading session and ended the day on $4.57. IDRA return on equity ratio is recorded as -444.00% and its return on assets is -114.30%. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) yearly performance is 814.00%.
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether CytRx Corporation (NASDAQ:CYTR) and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. CytRx Corporation (NASDAQ:CYTR) shares moved up 7.86% in last trading session and was closed at $3.43, while trading in range of $3.19 – $3.49. CytRx Corporation (NASDAQ:CYTR) year to date (YTD) performance is -45.30%.
On March 20, 2014, Corcept Therapeutics Incorporated (NASDAQ:CORT) entered into a manufacturing and supply agreement with Produits Chimiques Auxiliaires et de Syntheses SA. Corcept Therapeutics Incorporated (NASDAQ:CORT) weekly performance is -1.21%. On last trading day company shares ended up $4.07. Corcept Therapeutics Incorporated (NASDAQ:CORT) distance from 50-day simple moving average (SMA50) is 17.35%. Analysts mean target price for the company is $2.38.
Leave a Reply